Understanding TMX4: A Protein Implicated in Multiple Diseases

Target Name: TMX4

NCBI ID: G56255

TMX4

Understanding TMX4: A Protein Implicated in Multiple Diseases

TMX4 (TXNDC13) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, known as the histamine receptor-associated protein (HAP) family. HAPs are involved in many physiological processes in the body, including blood vessel dilation, muscle contractions, and inflammation.

TMX4 is also known as axon rescuer (Axon rescuer) or ALDH13A2, and it has been shown to have a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function in these diseases is still not well understood, but its potential as a drug target or biomarker is significant.

One of the main functions of TMX4 is its role in the regulation of angiogenesis, the process by which new blood vessels are formed. TMX4 has been shown to promote the formation of new blood vessels in various tissues, including the brain, and to regulate the diameter of these vessels. This may have implications for the treatment of various cardiovascular and neurological diseases, including heart failure, ischemia, and neurodegenerative disorders.

Another function of TMX4 is its role in the regulation of cell signaling, particularly in the regulation of the capital effect (HE) pathway. The HE pathway is a well-established pathway that involves the regulation of angiogenesis, cell survival, and inflammation. TMX4 has been shown to be involved in the regulation of this pathway, and its dysfunction may contribute to the development of various diseases.

In addition to its role in cell signaling, TMX4 may also be involved in the regulation of inflammation. Its expression has been shown in various tissues, including the brain, and it has been implicated in the regulation of inflammatory responses. This may have implications for the treatment of various inflammatory disorders, including autoimmune diseases and inflammatory bowel disease.

The role of TMX4 in cancer is also of interest. TMX4 has been shown to be involved in the regulation of cancer cell growth and survival, and its dysfunction in this pathway may contribute to the development and progression of cancer. This may have implications for the treatment of various cancers, including breast, lung, and ovarian cancers.

In conclusion, TMX4 is a protein that has been shown to have a role in several physiological processes in the body, including angiogenesis, cell signaling, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for research into the treatment of various diseases. Further studies are needed to fully understand its function and potential as a therapeutic agent.

Protein Name: Thioredoxin Related Transmembrane Protein 4

The "TMX4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMX4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets